Workflow
药明康德(603259)2024年年报点评:在手订单延续高增,多肽业务放量增长

Investment Rating - The report maintains a rating of "Accumulate" for WuXi AppTec (603259) with a target price of 93.84 CNY, up from the previous forecast of 71.82 CNY [1][11]. Core Views - The report highlights strong growth in backlog orders and a significant increase in peptide business, indicating a positive long-term growth outlook for the company [1][11]. - The company is expected to achieve a revenue of 39.24 billion CNY in 2024, reflecting a decrease of 2.7% year-on-year, while the net profit attributable to the parent company is projected at 9.45 billion CNY, down 1.6% [2][11]. - The report notes that the fourth quarter of 2024 is expected to show a revenue of 11.54 billion CNY, representing a 6.9% increase, with an adjusted net profit of 3.234 billion CNY, up 20.3% [11]. Financial Summary - Revenue and Profit Forecasts: - 2023A: Revenue 40.34 billion CNY, Net Profit 9.607 billion CNY - 2024A: Revenue 39.241 billion CNY, Net Profit 9.450 billion CNY - 2025E: Revenue 42.602 billion CNY, Net Profit 11.778 billion CNY - 2026E: Revenue 47.327 billion CNY, Net Profit 12.846 billion CNY - 2027E: Revenue 52.801 billion CNY, Net Profit 14.749 billion CNY [2][13]. - Earnings Per Share (EPS) Forecasts: - 2023A: 3.33 CNY - 2024A: 3.27 CNY - 2025E: 4.08 CNY - 2026E: 4.45 CNY - 2027E: 5.11 CNY [2][13]. - Return on Equity (ROE) Forecasts: - 2023A: 17.4% - 2024A: 16.1% - 2025E: 17.5% - 2026E: 16.8% - 2027E: 17.0% [2][13]. Market Data - The stock has a 52-week price range of 36.87 to 69.68 CNY, with a total market capitalization of 201.235 billion CNY [3][11]. - The company has a net asset value per share of 20.30 CNY and a price-to-book ratio of 3.4 [4][11]. Business Performance - The report indicates that the chemical business is expected to grow by 11.2% in 2024, excluding the impact of COVID-19 commercialization orders, with an adjusted gross margin of 46.4% [11]. - The peptide business (TIDES) is projected to achieve a revenue of 5.8 billion CNY in 2024, marking a 70.1% increase, with backlog orders growing by 103.9% [11].